SUVEN PHARMACEUTICALS
Back to Cashflow Statement
|
SUVEN PHARMACEUTICALS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹3.32 Cr | ₹-40 Cr | ₹-242 Cr | ₹-156 Cr | ₹-76 Cr |
What is the latest Cash Flow from Financing Activities ratio of SUVEN PHARMACEUTICALS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹3.32 Cr |
| Mar2024 | ₹-40 Cr |
| Mar2023 | ₹-242 Cr |
| Mar2022 | ₹-156 Cr |
| Mar2021 | ₹-76 Cr |
How is Cash Flow from Financing Activities of SUVEN PHARMACEUTICALS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹3.32 Cr | Positive | |
| Mar2024 | ₹-40 Cr | Negative | |
| Mar2023 | ₹-242 Cr | Negative | |
| Mar2022 | ₹-156 Cr | Negative | |
| Mar2021 | ₹-76 Cr | - | |
Compare Cash Flow from Financing Activities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹11,317.3 Cr | -0.6% | -12.9% | -75.6% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹434,999.0 Cr | 3.6% | 7% | 15.3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹169,139.0 Cr | 1.1% | 5.8% | 14.8% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,791.0 Cr | 1.9% | 12.3% | 49.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹109,664.0 Cr | 1.8% | 5.9% | 14.8% | Stock Analytics | |
| CIPLA | ₹107,685.0 Cr | 1.6% | 0.2% | -5.4% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -0.6% |
-12.9% |
-75.6% |
| SENSEX | -2.5% |
-6.1% |
7% |
You may also like the below Video Courses